In NSCLC tissue and cells, METTL3 and its target oncogenes Bcl-2, EZH2, and JUNB, are up-regulated, correlating with LC progression status (Wanna-Udom et al., 2020; Zhang et al., 2021a). Here, METTL3 is linked to non-small cell lung carcinoma.